Top Midday Gainers

MT newswire2026/10/09 16:06

12:06 PM EDT, 10/09/2026 (MT Newswires) -- Veea (VEEA) surged 67% amid heavy trading after the company said late Thursday it regained full compliance with Nasdaq's continued listing requirements. More than 68 million shares traded intraday, compared with a daily average of about 6.7 million. Humana (HUM) affirmed its full-year 2026 guidance of at least $9 in adjusted earnings per common share on Friday. Oppenheimer raised Humana's price target to $475 from $405 while maintaining its outperform rating. Shares jumped 13%, with intraday trading volume rising to over 2.8 million, versus a daily average of about 1.3 million. Moderna (MRNA) and other vaccine developers' shares rose after The New York Times reported that the National Institutes of Health is part of a public-private partnership to accelerate cancer vaccines' development. Shares climbed 9%, with intraday trading volume at over 15 million, versus a daily average of roughly 18 million. Price: 6.46, Change: +2.59, Percent Change: +66.93

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Crypto Liying: 10.12 bitcoin (BTC) and ethereum (ETH) latest market analysis and trading recommendations

AiCoin•2026/10/11 15:43

Meta Stock Warning? Zuckerberg Sells $21 Million as Insiders Exit

BeInCrypto•2026/10/11 15:03

Yueying: October 11-12 Bitcoin and Ethereum Market Analysis — Is the Recent Rebound a Bull Trap After a Short-term Peak? How to Handle Long Positions at High Levels?

AiCoin•2026/10/11 14:33

US Treasury Secretary Besant: Will continue to seize Iran's cryptocurrency, no military conflict expected before the mid-term elections

ForesightNews•2026/10/11 13:23